Shares of Stifel Financial were moving higher after it reported fourth-quarter adjusted earnings that beat Wall Street ...

The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...

Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

JMP Securities raised the firm’s price target on Stifel Financial (SF) to $135 from $125 and keeps an Outperform rating on the shares. Stifel ...

Stifel chief executive Ron Kruszewski said surging markets have forced firms to be particularly choosy about which advisors ...

Stifel Nicolaus analyst Ian Gillies maintained a Buy rating on Badger Infrastructure Solutions (BADFF – Research Report) today and set a price ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

Q4 2024 Earnings Conference Call January 29, 2025 9:30 AM ETCompany ParticipantsJoel Jeffrey - Senior Vice President ...

After the market closed yesterday, Stifel published new coverage on Datadog. The firm downgraded its rating on the stock from ...

ST. LOUIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors ...

Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $89.57 which represents a decrease of $-0.29 or -0.32% from the prior close of $89.86. The stock opened at $90.11 and touched a low of ...

Stifel expects DDOG’s challenges to hinder its revenue growth and profit margins this year. Noting that the company’s forward ...